JS-K

DB17257ExperimentalSmall molecule

JS-K: Overview.

Mechanism: Pharmacologically active on Glutathione S-transferases (Cytosolic)
Curator reviewed
Formula / weight: C₁₃H₁₆N₆O₈ · 384.305 g/mol (avg)
Also known as: 1-piperazinecarboxylic acid, 4-((2,4-dinitrophenoxy)-nno-azoxy)-, ethyl ester · 1-piperazinecarboxylic acid, 4-(2-(2,4-dinitrophenoxy)-1-oxidodiazenyl)-, ethyl ester · O2-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1-yl)diazen-1-ium-1,2-diolate · O2-(2,4-dinitrophenyl) 1-((4-ethoxycarbonyl)piperazin-1yl)diazen-1-ium-1,2-diolate
Code names: JS-K

Resolves to

Compound

Structure

InChIKeyDNJRNBYZLPKSHV-RGEXLXHISA-NSMILESCCOC(=O)N1CCN(CC1)[N+](\[O-])=N\OC1=CC=C(C=C1[N+]([O-])=O)[N+]([O-])=O

What you can answer from here — as of July 08, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

2+ReferencesStructured and connected to the statements they support

Which companies are running trials of JS-K, in which indications and phases, and which of those programs are still active?

Create a free account or log in to explore the full data card.